Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer

By Udom D.I.   Vigushin D.M.   Linardou H.   Graham H.   Palmieri C.   Coombes R.C.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 177-182

Elsevier

Access to resources Recommend Favorite

A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1375-1380

Science Publishers

Access to resources Recommend Favorite

Phase II study evaluating lapatinib in combination with nab -paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen

By Yardley Denise  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 457-464

Springer Publishing Company

Access to resources Recommend Favorite

Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival

By Heys Steven  

Breast Cancer Research and Treatment, Vol. 90, Iss. 2, 2005-03 ,pp. : 169-185

Springer Publishing Company

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite